Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3508 Limassol, Cyprus
Brameston 2.5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored tablets. The tablet can be divided into equal doses. |
Each tablet contains bromocriptine mesilate equivalent to 2.5 mg bromocriptine.
Excipient(s) with known effect:
This product contains 80 mg lactose.
For full list of excipients refer to point 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bromocriptine |
Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
PVC/Aluminium blisters. Pack-sizes of 30 and 1000 tablets.
PP containers with PE closure. Pack-size of 1000 tablets.
Not all pack-sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3508 Limassol, Cyprus
9125
Date of first authorization: 21 October 1983
Date of latest renewal: 02 February 2009
| Drug | Countries | |
|---|---|---|
| BRAMESTON | Cyprus, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
